1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Transforming Growth Factor Beta 1 Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Pirfenidone
  • 1.3.3 Galunisertib
  • 1.3.4 Others
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Transforming Growth Factor Beta 1 Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 IPF
  • 1.4.3 Cancer
  • 1.4.4 Others
• 1.5 Global Transforming Growth Factor Beta 1 Market Size & Forecast
  • 1.5.1 Global Transforming Growth Factor Beta 1 Consumption Value (2021 & 2025 & 2032)
  • 1.5.2 Global Transforming Growth Factor Beta 1 Sales Quantity (2021-2032)
  • 1.5.3 Global Transforming Growth Factor Beta 1 Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Roche
  • 2.1.1 Roche Details
  • 2.1.2 Roche Major Business
  • 2.1.3 Roche Transforming Growth Factor Beta 1 Product and Services
  • 2.1.4 Roche Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Roche Recent Developments/Updates
• 2.2 Shionogi Ltd
  • 2.2.1 Shionogi Ltd Details
  • 2.2.2 Shionogi Ltd Major Business
  • 2.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Product and Services
  • 2.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Shionogi Ltd Recent Developments/Updates
• 2.3 Acceleron Pharma Inc
  • 2.3.1 Acceleron Pharma Inc Details
  • 2.3.2 Acceleron Pharma Inc Major Business
  • 2.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product and Services
  • 2.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Acceleron Pharma Inc Recent Developments/Updates
• 2.4 Genzyme Corp
  • 2.4.1 Genzyme Corp Details
  • 2.4.2 Genzyme Corp Major Business
  • 2.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Product and Services
  • 2.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Genzyme Corp Recent Developments/Updates
• 2.5 Isarna Therapeutics GmbH
  • 2.5.1 Isarna Therapeutics GmbH Details
  • 2.5.2 Isarna Therapeutics GmbH Major Business
  • 2.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product and Services
  • 2.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Isarna Therapeutics GmbH Recent Developments/Updates
• 2.6 Scholar Rock
  • 2.6.1 Scholar Rock Details
  • 2.6.2 Scholar Rock Major Business
  • 2.6.3 Scholar Rock Transforming Growth Factor Beta 1 Product and Services
  • 2.6.4 Scholar Rock Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 Scholar Rock Recent Developments/Updates
• 2.7 Sirnaomics Inc
  • 2.7.1 Sirnaomics Inc Details
  • 2.7.2 Sirnaomics Inc Major Business
  • 2.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Product and Services
  • 2.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 Sirnaomics Inc Recent Developments/Updates
• 2.8 Eli Lilly and Co
  • 2.8.1 Eli Lilly and Co Details
  • 2.8.2 Eli Lilly and Co Major Business
  • 2.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Product and Services
  • 2.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 Eli Lilly and Co Recent Developments/Updates
• 2.9 Formation Biologics Inc
  • 2.9.1 Formation Biologics Inc Details
  • 2.9.2 Formation Biologics Inc Major Business
  • 2.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Product and Services
  • 2.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Formation Biologics Inc Recent Developments/Updates
• 2.10 Novartis AG
  • 2.10.1 Novartis AG Details
  • 2.10.2 Novartis AG Major Business
  • 2.10.3 Novartis AG Transforming Growth Factor Beta 1 Product and Services
  • 2.10.4 Novartis AG Transforming Growth Factor Beta 1 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 Novartis AG Recent Developments/Updates

3 Competitive Environment: Transforming Growth Factor Beta 1 by Manufacturer

• 3.1 Global Transforming Growth Factor Beta 1 Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Transforming Growth Factor Beta 1 Revenue by Manufacturer (2021-2026)
• 3.3 Global Transforming Growth Factor Beta 1 Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Transforming Growth Factor Beta 1 by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Transforming Growth Factor Beta 1 Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Transforming Growth Factor Beta 1 Manufacturer Market Share in 2025
• 3.5 Transforming Growth Factor Beta 1 Market: Overall Company Footprint Analysis
  • 3.5.1 Transforming Growth Factor Beta 1 Market: Region Footprint
  • 3.5.2 Transforming Growth Factor Beta 1 Market: Company Product Type Footprint
  • 3.5.3 Transforming Growth Factor Beta 1 Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Transforming Growth Factor Beta 1 Market Size by Region
  • 4.1.1 Global Transforming Growth Factor Beta 1 Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Transforming Growth Factor Beta 1 Consumption Value by Region (2021-2032)
  • 4.1.3 Global Transforming Growth Factor Beta 1 Average Price by Region (2021-2032)
• 4.2 North America Transforming Growth Factor Beta 1 Consumption Value (2021-2032)
• 4.3 Europe Transforming Growth Factor Beta 1 Consumption Value (2021-2032)
• 4.4 Asia-Pacific Transforming Growth Factor Beta 1 Consumption Value (2021-2032)
• 4.5 South America Transforming Growth Factor Beta 1 Consumption Value (2021-2032)
• 4.6 Middle East & Africa Transforming Growth Factor Beta 1 Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Transforming Growth Factor Beta 1 Sales Quantity by Type (2021-2032)
• 5.2 Global Transforming Growth Factor Beta 1 Consumption Value by Type (2021-2032)
• 5.3 Global Transforming Growth Factor Beta 1 Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Transforming Growth Factor Beta 1 Sales Quantity by Application (2021-2032)
• 6.2 Global Transforming Growth Factor Beta 1 Consumption Value by Application (2021-2032)
• 6.3 Global Transforming Growth Factor Beta 1 Average Price by Application (2021-2032)

7 North America

• 7.1 North America Transforming Growth Factor Beta 1 Sales Quantity by Type (2021-2032)
• 7.2 North America Transforming Growth Factor Beta 1 Sales Quantity by Application (2021-2032)
• 7.3 North America Transforming Growth Factor Beta 1 Market Size by Country
  • 7.3.1 North America Transforming Growth Factor Beta 1 Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Transforming Growth Factor Beta 1 Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Transforming Growth Factor Beta 1 Sales Quantity by Type (2021-2032)
• 8.2 Europe Transforming Growth Factor Beta 1 Sales Quantity by Application (2021-2032)
• 8.3 Europe Transforming Growth Factor Beta 1 Market Size by Country
  • 8.3.1 Europe Transforming Growth Factor Beta 1 Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Transforming Growth Factor Beta 1 Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Transforming Growth Factor Beta 1 Market Size by Region
  • 9.3.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Transforming Growth Factor Beta 1 Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Transforming Growth Factor Beta 1 Sales Quantity by Type (2021-2032)
• 10.2 South America Transforming Growth Factor Beta 1 Sales Quantity by Application (2021-2032)
• 10.3 South America Transforming Growth Factor Beta 1 Market Size by Country
  • 10.3.1 South America Transforming Growth Factor Beta 1 Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Transforming Growth Factor Beta 1 Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Transforming Growth Factor Beta 1 Market Size by Country
  • 11.3.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Transforming Growth Factor Beta 1 Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Transforming Growth Factor Beta 1 Market Drivers
• 12.2 Transforming Growth Factor Beta 1 Market Restraints
• 12.3 Transforming Growth Factor Beta 1 Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Transforming Growth Factor Beta 1 and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Transforming Growth Factor Beta 1
• 13.3 Transforming Growth Factor Beta 1 Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Transforming Growth Factor Beta 1 Typical Distributors
• 14.3 Transforming Growth Factor Beta 1 Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Transforming Growth Factor Beta 1 market size was valued at US$ 2034 million in 2025 and is forecast to a readjusted size of US$ 4148 million by 2032 with a CAGR of 10.8% during review period.
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
This report is a detailed and comprehensive analysis for global Transforming Growth Factor Beta 1 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Transforming Growth Factor Beta 1 market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Transforming Growth Factor Beta 1 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Transforming Growth Factor Beta 1 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Transforming Growth Factor Beta 1 market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transforming Growth Factor Beta 1
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transforming Growth Factor Beta 1 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Transforming Growth Factor Beta 1 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pirfenidone
Galunisertib
Others
Market segment by Application
IPF
Cancer
Others
Major players covered
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transforming Growth Factor Beta 1 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Transforming Growth Factor Beta 1, with price, sales quantity, revenue, and global market share of Transforming Growth Factor Beta 1 from 2021 to 2026.
Chapter 3, the Transforming Growth Factor Beta 1 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transforming Growth Factor Beta 1 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Transforming Growth Factor Beta 1 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Transforming Growth Factor Beta 1.
Chapter 14 and 15, to describe Transforming Growth Factor Beta 1 sales channel, distributors, customers, research findings and conclusion.